The safety and efficacy of benzbromarone in gout in Aotearoa New Zealand-Reference-Cited by-同舟云学术

The safety and efficacy of benzbromarone in gout in Aotearoa New Zealand

Published:2016-09 Issue:9 Volume:46 Page:1075-1080
ISSN:1444-0903
Container-title:Internal Medicine Journal
language:en
Short-container-title:Internal Medicine Journal

Author:

Stamp L. K.¹,Haslett J.¹,Frampton C.¹,White D.²,Gardner D.³,Stebbings S.⁴,Taylor G.⁵,Grainger R.⁶,Kumar R.⁷,Kumar S.⁸,Kain T.⁹,Porter D.¹⁰,Corkill M.¹¹,Cathro A.¹²,Metcalfe S.¹²,Wyeth J.¹²,Dalbeth N.¹³

Affiliation:

1. Deparment of Medicine; University of Otago; Christchurch New Zealand

2. Department of Rheumatology; Waikato Hospital; Hamilton New Zealand

3. Department of Rheumatology; Hawkes Bay DHB; Napier New Zealand

4. Department of Medicine; University of Otago; Dunedin New Zealand

5. Department of Rheumatology; Whanganui Hospital; Whanganui New Zealand

6. Department of Medicine; University of Otago; Wellington New Zealand

7. Department of Rheumatology; Taranaki Hospital; New Plymouth New Zealand

8. Department of Rheumatology; Middlemore Hospital; Auckland New Zealand

9. Deparment of Rheumatology; Tauranga Hospital; Tauranga New Zealand

10. Nelson Hospital; Nelson New Zealand

11. North Shore Hospital; Auckland New Zealand

12. Pharmaceutical Management Agency (PHARMAC); Wellington New Zealand

13. Department of Medicine; University of Auckland; Auckland New Zealand

Publisher

Wiley

Subject

Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/imj.13173/fullpdf

Reference11 articles.

1. Molecular identification of a renal urate-anion transporter that regulates blood urate levels;Enomoto;Nature,2002

2. Mouse GLUT9: evidences for a urate uniporter;Bibert;Am J Physiol Renal Physiol,2009

3. A benefit-risk assessment of benzbromarone in the treatment of gout. Was its withdrawal from the market in the best interests of patients?;Lee;Drug Saf,2008

4. 2012 American College of Rheumatology guidelines for the management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricaemia;Khanna;Arthritis Care Res,2012

5. British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout;Jordan;Rheumatology,2007

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of urolithiasis associated with allopurinol versus benzbromarone among patients with gout: a population-based cohort study;Rheumatology;2024-05-11

2. Fangyukangsuan granules ameliorate hyperuricemia and modulate gut microbiota in rats;Frontiers in Immunology;2024-04-30

3. Get on top of gout with a fresh look at treatment options;Drugs & Therapy Perspectives;2024-03

4. Lessons to be learned from real life data from 98 gout patients using benzbromarone;Exploration of Musculoskeletal Diseases;2023-10-30

5. Emerging Urate-Lowering Drugs and Pharmacologic Treatment Strategies for Gout: A Narrative Review;Drugs;2023-10-11